
Republican congressman Chris Collins, one of the first members of Congress to throw his support behind President Trump, reportedly resigned his congressional seat Monday a day before he is expected to plead guilty to insider-trading charges he had previously vowed to fight.
Collins, 69, is accused of working with his son, Cameron Collins, to avoid more than $700,000 in losses using confidential information about the Australian company Innate Immunotherapeutics. Collins, who was the company’s biggest investor and sat on its board, allegedly received private corporate information regarding a drug trial while at a White House congressional picnic, and contacted his son with the information.